- Report
- February 2024
- 80 Pages
Ireland
From €1343EUR$1,500USD£1,144GBP
- Report
- February 2024
- 80 Pages
Japan
From €1343EUR$1,500USD£1,144GBP
- Report
- February 2024
- 80 Pages
Russia
From €1343EUR$1,500USD£1,144GBP
- Report
- February 2024
- 80 Pages
Vietnam
From €1343EUR$1,500USD£1,144GBP
- Report
- October 2023
- 146 Pages
Global
From €3715EUR$4,150USD£3,164GBP
- Report
- April 2023
- 100 Pages
Africa
From €1790EUR$2,000USD£1,525GBP
- Report
- April 2024
- 132 Pages
Global
From €850EUR$950USD£724GBP
- Report
- August 2024
- 248 Pages
China
From €3581EUR$4,000USD£3,050GBP
- Report
- August 2024
- 104 Pages
China
From €1611EUR$1,800USD£1,373GBP
- Report
- November 2021
- 392 Pages
Global
From €2686EUR$3,000USD£2,288GBP
- Book
- August 2023
- 1360 Pages
- Book
- January 2025
- 496 Pages
- Book
- August 2023
- 1360 Pages
- Book
- December 2021
- 576 Pages
- Book
- September 2021
- 464 Pages
- Book
- October 2019
- 472 Pages
- Book
- May 2015
- 368 Pages
- Book
- January 2013
- 632 Pages
- Book
- September 2010
- 484 Pages

The Parenteral Administration market within the Healthcare Services sector is a rapidly growing industry. It involves the delivery of drugs, fluids, and other therapeutic substances directly into a patient's bloodstream. This method of drug delivery bypasses the digestive system, allowing for faster absorption and more precise dosing. It is used to treat a variety of conditions, including cancer, infections, and chronic diseases.
Parenteral Administration is a highly specialized field, requiring specialized equipment and personnel. It is often used in emergency situations, such as when a patient is unable to take oral medications. It is also used in the treatment of chronic conditions, such as diabetes, where precise dosing is essential.
The Parenteral Administration market is highly competitive, with a number of companies offering products and services. These include Baxter International, B. Braun Melsungen AG, Fresenius Kabi, Hospira, and Pfizer. Show Less Read more